Finance

Beta
Lists
UPB:NASDAQ
Upstream Bio Inc
$8.36
+0.48%
(+0.040) 1D
$8.36
0.00% (0.00)
After hours
Closed: May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for UPB...
Open
$8.31
High
$8.50
Low
$8.16
Mkt. cap
454.95M
Avg. vol.
543.54K
Volume
499.06K
52-wk high
$33.68
52-wk low
$7.25
EPS
-$2.90
Shares outstanding
54.42M
No. of employees
75
Open
$8.31
High
$8.50
Low
$8.16
Mkt. cap
454.95M
Avg. vol.
543.54K
Volume
499.06K
52-wk high
$33.68
52-wk low
$7.25
EPS
-$2.90
Shares outstanding
54.42M
No. of employees
75
News stories
From sources across the web
About Upstream Bio Inc
CEO-
Employees75
Founded2021
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Last report
May 13, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.75 / -$0.75
+0.50%beat
Revenue / Est. (USD)
1.03M / 347.17K
+197.84%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
937.00K
683.00K
668.00K
1.03M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
37.86M
32.98M
40.17M
36.56M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
7.42M
5.54M
6.67M
8.08M
Operating expense
45.28M
38.52M
46.84M
44.65M
Total operating expenses
45.28M
38.52M
46.84M
44.65M
Operating income
-44.35M
-37.83M
-46.17M
-43.62M
Other non operating income
-50.00K
-19.00K
54.00K
-30.00K
EBT including unusual items
-39.97M
-33.75M
-42.46M
-40.59M
EBT excluding unusual items
-39.97M
-33.75M
-42.46M
-40.59M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.97M
-33.75M
-42.46M
-40.59M
Net profit margin
-4,265.31%
-4,941.14%
-6,356.14%
-3,925.63%
Earnings per share
-0.74
-0.63
-0.78
-0.75
Interest and investment income
4.43M
4.10M
3.65M
3.05M
Interest expense
-
-
-
-
Net interest expenses
4.43M
4.10M
3.65M
3.05M
Depreciation and amortization charges
-
-
-
-
EBITDA
-44.30M
-37.79M
-46.11M
-43.57M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more